Personal information

Activities

Works (21)

Laboratory profiles of patients hospitalized with COVID-19 pneumonia treated with tofacitinib or placebo: a post hoc analysis from the STOP-COVID trial

einstein (São Paulo)
2024-10-17 | Journal article
Contributors: Patrícia Oliveira Guimarães; Lucas Petri Damiani; Caio de Assis Moura Tavares; Ari Stiel Radu Halpern; J. Jasper Deuring; Luiz Vicente Rizzo; Otavio Berwanger
Source: check_circle
Crossref

Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib.

Arthritis research & therapy
2024-08-27 | Journal article
Contributors: Hetland ML; Anja Strangfeld; Bonfanti G; Soudis D; Deuring JJ; Edwards RA
Source: Self-asserted source
J. Jasper Deuring

Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program

Advances in Therapy
2023-10 | Journal article
Contributors: Michael Chiorean; Marco Daperno; Charlie W. Lees; Gianluca Bonfanti; Dimitrios Soudis; Irene Modesto; J. Jasper Deuring; Roger A. Edwards
Source: check_circle
Crossref

Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies.

Therapeutic advances in gastroenterology
2021-11 | Journal article
Contributors: Lees CW; Deuring JJ; Chiorean M; Daperno M; Bonfanti G; Germino R; Brown PB; Modesto I; Edwards RA
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.

Inflammatory bowel diseases
2021-10 | Journal article
Contributors: Dubinsky MC; Watanabe K; Molander P; Peyrin-Biroulet L; Rubin M; Melmed GY; Deuring JJ; Woolcott J; Cappelleri JC; Steinberg K et al.
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views.

JGH open : an open access journal of gastroenterology and hepatology
2021-08 | Journal article
Contributors: Connor SJ; Sechi A; Andrade M; Deuring JJ; Witcombe D
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?

Current therapeutic research, clinical and experimental
2021-07 | Journal article
Contributors: Howland S; Deuring JJ; Zhou X; Chen Y; Mota LM; Ungaro RC
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.

The New England journal of medicine
2021-06 | Journal article
Contributors: Guimarães PO; Quirk D; Furtado RH; Maia LN; Saraiva JF; Antunes MO; Kalil Filho R; Junior VM; Soeiro AM; Tognon AP et al.
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.

Inflammatory bowel diseases
2021-06 | Journal article
Contributors: Rubin DT; Hart A; Panaccione R; Armuzzi A; Suvanto U; Deuring JJ; Woolcott J; Cappelleri JC; Steinberg K; Wingate L et al.
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.

PloS one
2019-10 | Journal article
Contributors: Deuring JJ; Li M; Cao W; Chen S; Wang W; de Haar C; van der Woude CJ; Peppelenbosch M
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Analysis of SHIP1 expression and activity in Crohn's disease patients.

PloS one
2017-08 | Journal article
Contributors: Somasundaram R; Fernandes S; Deuring JJ; de Haar C; Kuipers EJ; Vogelaar L; Middleton FA; van der Woude CJ; Peppelenbosch MP; Kerr WG et al.
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Dichotomal effect of space flight-associated microgravity on stress-activated protein kinases in innate immunity.

Scientific reports
2014-06 | Journal article
Contributors: Verhaar AP; Hoekstra E; Tjon AS; Utomo WK; Deuring JJ; Bakker ER; Muncan V; Peppelenbosch MP
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.

Science translational medicine
2014-04 | Journal article
Contributors: Parikh K; Zhou L; Somasundaram R; Fuhler GM; Deuring JJ; Blokzijl T; Regeling A; Kuipers EJ; Weersma RK; Nuij VJ et al.
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease.

Gut
2013-08 | Journal article
Contributors: Deuring JJ; Fuhler GM; Konstantinov SR; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease.

The international journal of biochemistry & cell biology
2013-01 | Journal article
Contributors: Deuring JJ; de Haar C; Kuipers EJ; Peppelenbosch MP; van der Woude CJ
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.

Molecular medicine (Cambridge, Mass.)
2012-12 | Journal article
Contributors: Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.

Carcinogenesis
2012-06 | Journal article
Contributors: Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding.

The Biochemical journal
2012-01 | Journal article
Contributors: Deuring JJ; de Haar C; Koelewijn CL; Kuipers EJ; Peppelenbosch MP; van der Woude CJ
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Linking risk conferring mutations in NCF4 to functional consequences in Crohn's disease.

Gut
2011-10 | Journal article
Contributors: Somasundaram R; Deuring JJ; van der Woude CJ; Peppelenbosch MP; Fuhler GM
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Impeded protein folding and function in active inflammatory bowel disease.

Biochemical Society transactions
2011-08 | Journal article
Contributors: Deuring JJ; Peppelenbosch MP; Kuipers EJ; van der Woude CJ; de Haar C
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central

Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.

Gut
2009-11 | Journal article
Contributors: Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Source: Self-asserted source
J. Jasper Deuring via Europe PubMed Central